The feature is live on the HealthPlix platform and optimised for prompting these interactions while the doctor prescribes the medicines to their patients
HealthPlix Technologies has announced the release of its new feature-‘Drug to Drug Interaction’ (DDI). DDI is an intuitive feature that sits on the HealthPlix EMR to help doctors recall molecule-to-molecule interactions at the time of care. The suggestive feature is designed for doctors in India and targeted to decrease their time taken to write a prescription.
The feature is live on the HealthPlix platform and optimised for prompting these interactions while the doctor prescribes the medicines to their patients.
A well-defined reference interactions library can assist doctors in identifying potentially unsafe combinations of medications. Furthermore, the company plans to ramp up its database/information by integrating with global third-party providers who specialise in drug-to-drug interactions. HealthPlix expects its reference interaction library to grow from 4L to 10L by March 2023.
Prior to DDI, HealthPlix has launched a slew of products like Doctor Insights Dashboard, Patient Summary Dashboard and Mobile EMR.